Was the implementation strategy of the ProACT trial adequately proactive?

Alexander G. Mathioudakis, Jørgen Vestbo
Breathe 2019 15: 77-80; DOI: 10.1183/20734735.0338-2018

Article Information

vol. 15 no. 1 77-80
DOI 
https://doi.org/10.1183/20734735.0338-2018
Published By 
European Respiratory Society
Print ISSN 
1810-6838
Online ISSN 
2073-4735
History 
  • Published online March 1, 2019.
Copyright & Usage 
Copyright ©ERS 2019 Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Alexander G. Mathioudakis⇑ and
  2. Jørgen Vestbo
  1. Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester, UK.
  1. E-mail: alexander.mathioudakis{at}manchester.ac.uk
View Full Text

Article usage

Article usage: February 2019 to April 2023

AbstractFullPdf
Feb 2019021
Mar 20191046155
Apr 2019511428
May 2019410438
Jun 201956115
Jul 201955815
Aug 201914579
Sep 20190536
Oct 201987817
Nov 201975713
Dec 201924010
Jan 202057410
Feb 20200486
Mar 20202297
Apr 20202245
May 202012713
Jun 20201266
Jul 202022414
Aug 20201267
Sep 20204437
Oct 20208347
Nov 20200377
Dec 202012814
Jan 202113511
Feb 20210278
Mar 202122914
Apr 202112316
May 202112412
Jun 202112010
Jul 202111811
Aug 20210154
Sep 202112510
Oct 202103136
Nov 202102016
Dec 20210426
Jan 20220271
Feb 20220163
Mar 20221258
Apr 20221143
May 202201712
Jun 20220184
Jul 20220243
Aug 20221213
Sep 20221148
Oct 20221227
Nov 2022186
Dec 20220713
Jan 20230136
Feb 20230161
Mar 20233175
Apr 2023844

Altmetrics

Back to top
Email
Print
Citation Tools

Was the implementation strategy of the ProACT trial adequately proactive?
Alexander G. Mathioudakis, Jørgen Vestbo
Breathe Mar 2019, 15 (1) 77-80; DOI: 10.1183/20734735.0338-2018
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

Subjects